VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FHTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FHTXFoghorn Therapeutics Inc.
$1.87$110M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFHTXQuarterly Cash Flow

Foghorn Therapeutics Inc. (FHTX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Foghorn Therapeutics Inc. (FHTX) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

FHTX Cash Flow Statement

Quarterly statement

FHTX Cash Flow Statement

Foghorn Therapeutics Inc. (FHTX) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-18.9M-25.27M-22.27M-18.86M-21M-23.97M-24.52M-21M-25.54M-29.34M-27.54M-27.21M-32.17M-31.18M-28.92M-19.99M-29.01M271.53M11.88M-20.5M
Operating CF Margin %-117.61%-773.37%-240.85%-231.33%-277.89%-402.69%-858.51%-269.02%-370.75%-581.09%-477.4%-155.68%-574.66%-587.3%-691.3%-301.27%-646.15%6926.89%1666.48%-50004.88%
Operating CF Growth %9.99%-5.42%9.17%10.21%17.77%18.32%10.97%22.8%20.63%5.89%4.78%-36.15%-10.9%-111.48%-343.43%2.52%-56.97%1273.09%211.52%-852.09%
Net Income-7.19M-19.88M-21.66M-15.85M-17.94M-18.83M-19.5M-19.12M-22.98M-25.02M-24.11M-14.35M-29.49M-30.49M-28.89M-25.77M-27.31M-26.91M-29.14M-26.08M
Depreciation & Amortization230K238K802K852K851K827K761K733K791K835K852K864K2.17M859K2.92M1.1M1.96M1.93M810K861K
Stock-Based Compensation2.55M2.38M2.24M02.73M2.69M2.48M003.22M3.05M4.09M04.57M00002.08M2.37M
Deferred Taxes00000000000000000000
Other Non-Cash Items-21.62M173K4.55M3.07M1.07M631K-141K2.62M6.31M865K900K673K3.74M430K3.21M3.38M3.18M3.28M2.48M1.22M
Working Capital Changes7.13M-8.19M-8.2M-6.94M-7.72M-9.28M-8.12M-5.23M-9.66M-9.25M-8.24M-18.5M-8.59M-6.55M-6.17M1.31M-6.83M293.24M35.65M1.12M
Change in Receivables00000000000000000300M00
Change in Inventory00000000000000000000
Change in Payables-69K-990K1.05M-110K-747K284K334K-1.35M-829K-629K-236K-438K-171K1.69M157K1.62M-1.44M1.27M-21K415K
Cash from Investing-2.97M-17.72M13.23M35.57M33.83M29.4M22.29M-61.31M-17.98M27.09M37.38M38.43M39.13M29.5M-6.51M46.05M-124.46M-159.41M9.67M-47.33M
Capital Expenditures-50K000-22K-28K-479K-309K-17K-101K-37K-82K-469K-636K-269K-330K-364K-247K-80K-230K
CapEx % of Revenue0.31%---0.29%0.47%16.77%3.96%0.25%2%0.64%0.47%8.38%11.98%6.43%4.97%8.11%6.3%11.22%560.98%
Acquisitions00000000000000000000
Investments--------------------
Other Investing0000000000-1K1K00000000
Cash from Financing-49.79M49.77M581K49K254K139K4K1.05M103.21M1.17M186K1.39M103K102K16K333K1.03M384K21.74M505K
Debt Issued (Net)000000000000000000-21.2M0
Equity Issued (Net)-49.77M49.77M581K49K254K139K01.44M103.4M000103K016K333K1.03M384K00
Dividends Paid00000000000000000000
Share Repurchases-49.77M0000000000000000000
Other Financing-22K000004K-390K-195K1.17M186K1.39M0102K000042.95M505K
Net Change in Cash-71.66M6.79M-8.46M16.76M12.8M5.57M-2.22M-81.27M59.69M-1.08M10.03M12.6M7.06M-1.57M-35.41M26.42M-152.44M112.51M43.3M-67.33M
Free Cash Flow-18.95M-25.27M-22.27M-18.86M-21.02M-24M-25M-21.31M-25.55M-29.45M-27.58M-27.29M-32.64M-31.82M-29.19M-20.32M-29.38M271.29M11.8M-20.73M
FCF Margin %-117.93%-773.37%-240.85%-231.33%-278.18%-403.16%-875.28%-272.98%-370.99%-583.09%-478.04%-156.15%-583.03%-599.28%-697.73%-306.24%-654.25%6920.59%1655.26%-50565.85%
FCF Growth %9.84%-5.29%10.91%11.51%17.73%18.51%9.36%21.9%21.72%7.45%5.53%-34.34%-11.12%-111.73%-347.36%2.01%-49.18%1187.72%165.05%-668.14%
FCF per Share-0.27-0.36-0.35-0.30-0.33-0.38-0.40-0.34-0.50-0.69-0.65-0.65-0.78-0.76-0.70-0.49-0.716.560.32-0.56
FCF Conversion (FCF/Net Income)2.63x1.27x1.03x1.19x1.17x1.27x1.26x1.10x1.11x1.17x1.14x1.90x1.09x1.02x1.00x0.78x1.06x-10.09x-0.41x0.79x
Interest Paid000000000000000000498K408K
Taxes Paid001K04K4K47K0049K865K996K00000000